Revisions of '"Apple core" colonic adenocarcinoma with obstruction and fecalization'
-
Revision 4 - created 5 months ago by Ryan Thibodeau - view changesetDate: 2023-12-13 00:07:04 UTC Disclosures:
At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.
View Ryan Thibodeau's current disclosures Reviewed by: Joachim Feger -
Revision 3 - created 7 months ago by Ryan Thibodeau - view changesetDate: 2023-10-13 00:18:02 UTC Disclosures:
At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.
View Ryan Thibodeau's current disclosures Reviewed by: Ryan Thibodeau -
Revision 2 - created 7 months ago by Dalia Ibrahim - view changesetDate: 2023-10-12 16:40:05 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Ryan Thibodeau -
Revision 1 - created 7 months ago by Michael P Hartung - view changesetDate: 2023-10-11 18:07:05 UTC Disclosures:
At the time the revision was created Michael P Hartung had the following disclosures:
- Otsuka Pharmaceutical, Consultant (past)
- Innovenn, Inc, Consultant (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Michael P Hartung's current disclosures Reviewed by: Ryan Thibodeau
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.